Finance

Lists
300573:SHE
Shenyang Xingqi Pharmaceutical Co Ltd
CNÂ¥35.58
-0.84%
(-0.30) 1D
Sep 28, 3:04:25 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300573...
Open
CNÂ¥35.88
High
CNÂ¥36.08
Low
CNÂ¥35.41
Mkt. cap
12.73B
Avg. vol.
5.29M
Volume
2.90M
Dividend
2.78%
Quarterly dividend
CNÂ¥0.25
Ex-dividend date
Sep 23, 2026
P/E ratio
16.08
52-wk high
CNÂ¥59.07
52-wk low
CNÂ¥35.10
EPS
CNÂ¥2.21
Shares outstanding
354.92M
No. of employees
2K
Open
CNÂ¥35.88
High
CNÂ¥36.08
Low
CNÂ¥35.41
Mkt. cap
12.73B
Avg. vol.
5.29M
Volume
2.90M
Dividend
2.78%
Quarterly dividend
CNÂ¥0.25
Ex-dividend date
Sep 23, 2026
P/E ratio
16.08
52-wk high
CNÂ¥59.07
52-wk low
CNÂ¥35.10
EPS
CNÂ¥2.21
Shares outstanding
354.92M
No. of employees
2K
About Shenyang Xingqi Pharmaceutical Co Ltd
CEO-
Employees2.4K
FoundedMar 24, 1977
Headquarters-
SectorPharmaceutical industry
Websitesinqi.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
740.99M
569.12M
683.34M
717.54M
Cost of goods sold
123.12M
122.47M
122.64M
125.94M
Cost of revenue
123.12M
122.47M
122.64M
125.94M
Research and development expenses
63.36M
70.79M
84.47M
76.83M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
230.42M
264.11M
241.35M
252.92M
Operating expense
286.99M
351.25M
331.32M
338.13M
Total operating expenses
410.12M
473.72M
453.96M
464.08M
Operating income
330.87M
95.41M
229.38M
253.46M
Other non operating income
-1.22M
475.40K
797.23K
-1.14M
EBT including unusual items
304.06M
111.50M
230.12M
252.18M
EBT excluding unusual items
330.73M
93.98M
230.10M
254.28M
Income tax expense
39.98M
14.56M
23.71M
28.19M
Effective tax rate
13.15%
13.05%
10.30%
11.18%
Other operating expenses
-10.95M
20.05M
4.96M
7.76M
Net income
264.08M
96.95M
206.41M
223.99M
Net profit margin
35.64%
17.03%
30.21%
31.22%
Earnings per share
-
-
-
-
Interest and investment income
462.25K
399.40K
408.35K
453.55K
Interest expense
-1.00M
-631.22K
-481.32K
-195.66K
Net interest expenses
-538.91K
-231.82K
-72.97K
257.89K
Depreciation and amortization charges
-
-
-
-
EBITDA
353.72M
120.67M
254.64M
283.39M
Gain or loss from assets sale
74.80K
-52.54K
-
-7.97K
AI content may include mistakes. Learn more
Google apps